Bingfeng Liang & Dangxia Zhou. (2021). ROS-Activated homodimeric podophyllotoxin nanomedicine with self-accelerating drug release for efficient cancer eradication. Taylor & Francis Group.
Chicago Style (17th ed.) CitationBingfeng Liang and Dangxia Zhou. ROS-Activated Homodimeric Podophyllotoxin Nanomedicine with Self-accelerating Drug Release for Efficient Cancer Eradication. Taylor & Francis Group, 2021.
MLA (9th ed.) CitationBingfeng Liang and Dangxia Zhou. ROS-Activated Homodimeric Podophyllotoxin Nanomedicine with Self-accelerating Drug Release for Efficient Cancer Eradication. Taylor & Francis Group, 2021.
Warning: These citations may not always be 100% accurate.